Singapore reports four cases of heart inflammation after second jab of mRNA Covid-19 vaccines

The Pfizer-BioNTech and Moderna Covid-19 vaccines both use mRNA technology. - Reuters

SINGAPORE, June 12 (Bernama): Singapore has reported four cases of heart inflamation involving young men aged between 18 to 30 years after taking the second dose of mRNA Covid-19 vaccines.

The republic's Expert Committee on Covid-19 Vaccination in a statement issue late Friday said most cases of "myocarditis and pericarditis" were reported to have occurred within a few days after receiving the second dose of the vaccine.